ASX:ATHASX:ATHBiotechsWe're Keeping An Eye On Alterity Therapeutics' (ASX:ATH) Cash Burn RateJune 28, 2022Just because a business does not make any money, does not mean that the stock will go down. For example, although...
ASX:CSLASX:CSLBiotechsIs CSL Limited's (ASX:CSL) Latest Stock Performance A Reflection Of Its Financial Health?June 28, 2022Most readers would already be aware that CSL's (ASX:CSL) stock increased significantly by 5.0% over the past week...
ASX:KZAASX:KZABiotechsWe're Not Worried About Kazia Therapeutics' (ASX:KZA) Cash BurnJune 24, 2022Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
ASX:PARASX:PARBiotechsHere's Why We're Not Too Worried About Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn SituationJune 20, 2022Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
ASX:PTXASX:PTXBiotechsPrescient Therapeutics (ASX:PTX) Is In A Strong Position To Grow Its BusinessJune 19, 2022There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
ASX:RGSASX:RGSBiotechsThis Insider Has Just Sold Shares In Regeneus Ltd (ASX:RGS)June 19, 2022Investors may wish to note that the Chief Scientific Officer & Executive Director of Regeneus Ltd , Graham Vesey...
ASX:ACWASX:ACWBiotechsWhile shareholders of Actinogen Medical (ASX:ACW) are in the black over 3 years, those who bought a week ago aren't so fortunateJune 16, 2022Actinogen Medical Limited ( ASX:ACW ) shareholders might understandably be very concerned that the share price has...
ASX:ARXASX:ARXBiotechsInvestors one-year losses grow to 37% as the stock sheds NZ$27m this past weekJune 16, 2022The simplest way to benefit from a rising market is to buy an index fund. Active investors aim to buy stocks that...
ASX:CUVASX:CUVBiotechsHave Clinuvel Pharmaceuticals Limited (ASX:CUV) Insiders Been Selling Their Stock?June 15, 2022We'd be surprised if Clinuvel Pharmaceuticals Limited ( ASX:CUV ) shareholders haven't noticed that the Non-Executive...